Nebula Data Intel is a new initiative focused on utilizing data to improve patient outcomes and elevate medicine worldwide. Founded in 2017, NDI’s focus is to utilize data and data insights to help tackle the biggest challenges facing today’s healthcare industry:

  • Employing Big Data to address pain points
  • Implementing value-based reimbursement
  • Pricing transparency
  • Addressing rising pharmaceutical costs
  • Complication rates
  • Technology acquisitions and investments
  • Complying with new government requirements and mandates

By working in collaboration with AAAASF, we can generate specialty-specific intelligent medical data from outpatient surgical centers. We rely on a robust team of medical and business experts as well as legal support to ensure that we maintain the highest quality standards in data, compliance, confidentiality, and business viability.

Executive Team

Dr. David Watts

CEO and Chairman of the Board of Directors

Read Dr. Watt's Bio

Dr. Larry S. Reed

Vice Chairman of the Board of Directors

No LinkedIn

Read Dr. Reed's Bio

Dr. Samuel Lin

Director of Research

Read Dr. Lin's Bio

Lisa Stichert

Chief Strategy Officer

Read Lisa's Bio

Jeffrey Mazza

Director of Finance

Read Jeffrey's Bio

Advisory Board

Adam Zeck


Read Adam's Bio

Jack Bouroudjian

Chief Economist

Read Jack's Bio

Doug Gisby


Read Doug's Bio

Ryan Ripa

VP of Product Management and Technical Sales

Read Ryan's Bio

Jim Valentine

Clinical Professor and the Executive Director of the Driehaus Center for Behavioral Finance

Read Jim's Bio

Business Partners